AGEN beat EPS expectations by 21.32%
Mar 13, 2025, 10:31 PM
0.00%
What does AGEN do
Agenus, a US-based biotechnology company headquartered in Lexington, specializes in immuno-oncology therapies targeting cancer and infectious diseases, employing 389 staff. Its pipeline includes advanced antibodies and various immunotherapy classes.
Agenus (AGEN) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Agenus's actual EPS was -$2.04, beating the estimate of -$2.59 per share, resulting in a 21.32% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.